Teladoc Inc (NYSE:TDOC) VP Mark Hirschhorn sold 20,000 shares of Teladoc stock in a transaction that occurred on Tuesday, July 10th. The stock was sold at an average price of $63.00, for a total value of $1,260,000.00. The sale was disclosed in a document filed with the SEC, which is accessible through this link.
Mark Hirschhorn also recently made the following trade(s):
- On Wednesday, May 2nd, Mark Hirschhorn sold 69,460 shares of Teladoc stock. The stock was sold at an average price of $43.73, for a total value of $3,037,485.80.
TDOC stock traded up $2.75 during midday trading on Thursday, hitting $65.45. The stock had a trading volume of 1,371,124 shares, compared to its average volume of 1,097,646. The stock has a market capitalization of $3.88 billion, a P/E ratio of -38.64 and a beta of 0.41. The company has a debt-to-equity ratio of 0.38, a quick ratio of 4.15 and a current ratio of 4.15. Teladoc Inc has a 12-month low of $27.30 and a 12-month high of $65.75.
Teladoc (NYSE:TDOC) last announced its quarterly earnings data on Tuesday, May 1st. The health services provider reported ($0.39) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.43) by $0.04. Teladoc had a negative net margin of 41.06% and a negative return on equity of 20.40%. The company had revenue of $89.64 million during the quarter, compared to analysts’ expectations of $86.77 million. During the same period in the previous year, the company earned ($0.30) EPS. The business’s quarterly revenue was up 109.0% compared to the same quarter last year. research analysts forecast that Teladoc Inc will post -1.45 earnings per share for the current fiscal year.
A number of institutional investors have recently made changes to their positions in TDOC. Teacher Retirement System of Texas purchased a new stake in Teladoc during the 4th quarter worth $480,000. Bank of New York Mellon Corp boosted its position in Teladoc by 63.0% during the 4th quarter. Bank of New York Mellon Corp now owns 465,917 shares of the health services provider’s stock worth $16,237,000 after purchasing an additional 180,129 shares during the period. BlackRock Inc. boosted its position in Teladoc by 7.4% during the 4th quarter. BlackRock Inc. now owns 4,971,297 shares of the health services provider’s stock worth $173,252,000 after purchasing an additional 342,715 shares during the period. Geode Capital Management LLC boosted its position in Teladoc by 16.4% during the 4th quarter. Geode Capital Management LLC now owns 428,312 shares of the health services provider’s stock worth $14,926,000 after purchasing an additional 60,205 shares during the period. Finally, Amundi Pioneer Asset Management Inc. boosted its position in Teladoc by 9.7% during the 4th quarter. Amundi Pioneer Asset Management Inc. now owns 273,695 shares of the health services provider’s stock worth $9,538,000 after purchasing an additional 24,176 shares during the period.
Several research analysts recently issued reports on the company. Jefferies Financial Group set a $74.00 price objective on Teladoc and gave the stock a “buy” rating in a research report on Wednesday. MED lifted their price objective on Teladoc to $56.00 and gave the stock a “hold” rating in a research report on Thursday, June 7th. Craig Hallum set a $39.00 price objective on Teladoc and gave the stock a “hold” rating in a research report on Wednesday, May 2nd. Canaccord Genuity lifted their price objective on Teladoc from $47.00 to $63.00 and gave the stock a “buy” rating in a research report on Tuesday, June 5th. Finally, Citigroup lifted their price objective on Teladoc to $62.00 and gave the stock a “buy” rating in a research report on Tuesday, June 5th. One analyst has rated the stock with a sell rating, five have given a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $53.63.
Teladoc Company Profile
Teladoc, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.
Receive News & Ratings for Teladoc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc and related companies with MarketBeat.com's FREE daily email newsletter.